Abstract:Background: p63 is a transcription factor with intrinsic pioneer factor activity and pleiotropic functions. Transforming growth factor β (TGFβ) signaling via activation and cooperative action of canonical, SMAD, and non-canonical, MAP-kinase (MAPK) pathways, elicits both anti- and pro-tumorigenic properties, including cell stemness and invasiveness. TGFβ activates the ΔNp63 transcriptional program in cancer cells; however, the link between TGFβ and p63 in unmasking the epigenetic landscape during tumor progression allowing chromatin accessibility and gene transcription, is not yet reported. Methods: Small molecule inhibitors, including protein kinase inhibitors and RNA-silencing, provided loss of function analyses. Sphere formation assays in cancer cells, chromatin immunoprecipitation and mRNA expression assays were utilized in order to gain mechanistic evidence. Mass spectrometry analysis coupled to co-immunoprecipitation assays revealed novel p63 interactors and their involvement in p63-dependent transcription. Results: The sphere-forming capacity of breast cancer cells was enhanced upon TGFβ stimulation and significantly decreased upon ΔNp63 depletion. Activation of TGFβ signaling via p38 MAPK signaling induced ΔNp63 phosphorylation at Ser 66/68 resulting in stabilized ΔNp63 protein with enhanced DNA binding properties. TGFβ stimulation altered the ratio of H3K27ac and H3K27me3 histone modification marks, pointing towards higher H3K27ac and increased p300 acetyltransferase recruitment to chromatin. By silencing the expression of ΔNp63, the TGFβ effect on chromatin remodeling was abrogated. Inhibition of H3K27me3, revealed the important role of TGFβ as the upstream signal for guiding ΔNp63 to the TGFβ/SMAD gene loci, as well as the indispensable role of ΔNp63 in recruiting histone modifying enzymes, such as p300, to these genomic regions, regulating chromatin accessibility and gene transcription. Mechanistically, TGFβ through SMAD activation induced dissociation of ΔNp63 from NURD or NCOR/SMRT histone deacetylation complexes, while promoted the assembly of ΔNp63-p300 complexes, affecting the levels of histone acetylation and the outcome of ΔNp63-dependent transcription. Conclusions: ΔNp63, phosphorylated and recruited by TGFβ to the TGFβ/SMAD/ΔNp63 gene loci, promotes chromatin accessibility and transcription of target genes related to stemness and cell invasion.

p63: a crucial player in epithelial stemness regulation

Distinct interactors define the p63 transcriptional signature in epithelial development or cancer

p63-related signaling at a glance

Role of P63 in Development, Tumorigenesis and Cancer Progression

P63 regulates tubular formation via epithelial-to-mesenchymal transition

STAT3 and p63 in the Regulation of Cancer Stemness

Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders

Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy

P63 in health and cancer

Pathway Regulation of p63, a Director of Epithelial Cell Fate

p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model

The Dual Role of P63 in Cancer

STAT3, stem cells, cancer stem cells and p63

p63 and its isoforms as markers of rat oral mucosa epidermal stem cells in vitro.

Pim2 Regulates Stemness Through Phosphorylation of 4E-Bp1

ΔNp63 bookmarks and creates an accessible epigenetic environment for TGFβ-induced cancer cell stemness and invasiveness

Master regulatory role of p63 in epidermal development and disease

TP63 Links Chromatin Remodeling and Enhancer Reprogramming to Epidermal Differentiation and Squamous Cell Carcinoma Development

Abstract 1820: TP63 Regulation of Epithelial to Mesenchymal Transition in an Experimental Prostate Cell Model.

Tp63 in Oral Development, Neoplasia, and Autoimmunity

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation